BRIGHT MINDS BIOSCIENCES INC. (DRUG) Executive Compensation
BRIGHT MINDS BIOSCIENCES INC. (DRUG) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DRUG
CIK: 1827401
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
De Visser Gray LLP
Auditor SinceSince 9/30/2020 12:00:00 AM
Lead Engagement PartnerWilliam Nichols
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-02 | 2026-03-31 | FORM 6-K | 0001062993-26-005170 | View SEC Doc Filr Page |
| 6-K | 2026-10-01 | 2026-09-30 | FORM 6-K | 0001062993-26-005123 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-06-30 | FORM 6-K | 0001062993-26-004442 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003688 | View SEC Doc Filr Page |
| S-8 | 2026-08-13 | — | FORM S-8 | 0001062993-26-004235 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004968 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-02 | — | SCHEDULE 13D/A Filing | 0001062993-26-003506 | View SEC Doc Filr Page |
| 6-K | 2026-06-03 | 2026-03-31 | FORM 6-K | 0001062993-26-003005 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-01-20 | FORM 6-K | 0001062993-26-002975 | View SEC Doc Filr Page |
| 6-K | 2026-05-28 | 2026-05-26 | 6-K Filing | 0002060755-26-000031 | View SEC Doc Filr Page |
| 6-K | 2026-05-20 | 2026-03-31 | FORM 6-K | 0001062993-26-002801 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000902664-26-002546 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000135 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000134 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0001213900-26-055371 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-30 | — | SCHEDULE 13G/A Filing | 0000929638-26-001709 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | 4 Filing | 0000929638-26-001708 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001274173-26-000081 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001831942-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001193125-26-054519 | View SEC Doc Filr Page |
| 6-K | 2026-02-13 | 2025-12-31 | FORM 6-K | 0001062993-26-000881 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-06 | — | SCHEDULE 13G/A Filing | 0001172661-26-000518 | View SEC Doc Filr Page |
| 6-K | 2026-01-09 | 2026-01-09 | FORM 6-K | 0001062993-26-000151 | View SEC Doc Filr Page |
| 6-K | 2026-01-09 | 2026-01-07 | FORM 6-K | 0001062993-26-000138 | View SEC Doc Filr Page |
| 424B5 | 2026-01-09 | — | FORM 424B5 | 0001062993-26-000136 | View SEC Doc Filr Page |